Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.

Original languageEnglish
JournalJournal of Microbiology, Immunology and Infection
Publication statusE-pub ahead of print - May 21 2019
Externally publishedYes

Fingerprint Dive into the research topics of 'Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy'. Together they form a unique fingerprint.

Cite this